Cardioxane--ICRF-187 towards anticancer drug specificity through selective toxicity reduction.
EuroCetus B.V., Amsterdam, The Netherlands.
J
J
Koning
P
P
Palmer
C R
CR
Franks
D E
DE
Mulder
J L
JL
Speyer
M D
MD
Green
K
K
Hellmann
D000818:Animals; D000970:Antineoplastic Agents / Q000009:adverse effects*; D006321:Heart / Q000187:drug effects*; D006801:Humans; D011929:Razoxane / Q000494:pharmacology*
D000970:Antineoplastic Agents; D011929:Razoxane